Defence Therapeutics Inc.
DTC
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.67M | -2.99M | -8.53M | -9.72M | -10.03M |
| Total Depreciation and Amortization | 73.50K | 83.10K | 70.40K | 66.90K | 32.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 672.40K | -1.30M | 4.63M | 4.57M | 4.46M |
| Change in Net Operating Assets | -270.40K | 1.67M | 1.78M | 1.91M | 1.14M |
| Cash from Operations | -2.19M | -2.53M | -2.06M | -3.18M | -4.39M |
| Capital Expenditure | 12.40K | -146.10K | -146.10K | -150.90K | -167.00K |
| Sale of Property, Plant, and Equipment | 13.30K | 13.30K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 25.70K | -132.80K | -146.10K | -150.90K | -167.00K |
| Total Debt Issued | 65.00K | 65.00K | 65.00K | 50.00K | 0.00 |
| Total Debt Repaid | -187.60K | -202.10K | -72.60K | -59.50K | -45.50K |
| Issuance of Common Stock | 5.03M | 2.69M | 1.89M | 1.89M | 4.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -268.80K | -146.00K | -124.60K | -124.60K | -246.30K |
| Cash from Financing | 3.24M | 1.77M | 1.30M | 1.30M | 2.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | -- |
| Net Change in Cash | 1.08M | -900.30K | -899.80K | -2.03M | -1.76M |